UNSPSC 51414101: Regadenoson

This classification denotes a vasodilating agent with the molecular formula C15H18N8O5.H2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2XLN4Y044H, chemically known as adenosine, 2-(4-((methylamino)carbonyl)-1h-pyrazol-1-yl)- but generally known as regadenoson, which bears US NIH Compound Identifier 219024. European Medicines Agency schedules Regadenoson in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB30494.

UNSPSC 51414101 Regadenoson is a Commodity code under which state and local governments procure injectable cardiac stress-test and emergency cardiovascular medications for fire rescue and emergency medical services operations. Based on recent solicitations, the work involves supply contracts for advanced life support medications — specifically epinephrine, adenosine, labetalol, diltiazem, and related agents — in unit quantities ranging from hundreds to low thousands of vials or injections per contract year. These are shelf-stock procurements with strict expiration-date and delivery-timeline requirements, typically awarded to the lowest responsive, responsible bidder through sealed IFB. Issuing bodies include city purchasing departments acting on behalf of fire rescue divisions and emergency services providers within their jurisdictions.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26-P-00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with a due date of April 8, 2026, and an estimated contract value of $40,000. The solicitation called for four medication line items totaling approximately 3,550 units, with nine-month minimum expiration requirements, ten-day delivery windows, and one-year initial terms with renewal and extension options. The notice included a 5 percent SLBE bid discount not to exceed $10,000 and required vendors to provide OSHA Safety Data Sheets and WCAG 2.2 Level AA accessibility documentation. Recent activity under this code is concentrated in Florida; broader geographic spread and repeat-buyer patterns are not evident from the available opportunities sample.